HIV: Cell Binding and Entry

Cited by (658)

Items 101–200 of 658

1. HIV integration in the human brain is linked to microglial activation and 3D genome remodeling
   A. Plaza-Jennings, A. Valada, Callan O’Shea, Marina Iskhakova, Benxia Hu, B. Javidfar, Gabriella Ben Hutta, Tova Y. Lambert, Jacinta M. Murray, Bibi S. Kassim et al. · 2022 · Molecules and Cells
2. Current status of mannose receptor-targeted drug delivery for improved anti-HIV therapy
   Satish V. Rojekar, Amol Dilip Gholap, Namdev S. Togre, Priyanka S. Bhoj, Clément M. Haeck, Navnath Tulshiram Hatvate, Nidhi Singh, Jyotsna G. Vitore, Sagar Dhoble, Snehal Kashid et al. · 2024 · Journal of Controlled Release
3. Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1
   George K. Lewis, Andrés Finzi, Anthony L. DeVico, Marzena Pazgier · 2015 · Viruses
4. Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections
   Sarah R. DiNapoli, Vanessa M. Hirsch, Jason M. Brenchley · 2016 · Journal of Virology
5. The Interplay between Viruses and Host DNA Sensors
   Sandra Huérfano, Vojtěch Šroller, Kateřina Bruštíková, Lenka Horníková, Jitka Forstová · 2022 · Viruses
6. Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches
   Alessandra Monti, Luigi Vitagliano, Andrea Caporale, Menotti Ruvo, Nunzianna Doti · 2023 · International Journal of Molecular Sciences
7. The biochemical basis of disease
   A. Barr · 2018 · Essays in Biochemistry
8. Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
   Yuta Hikichi, Rachel Van Duyne, Phuong Pham, Jennifer L. Groebner, Ann P. Wiegand, John W. Mellors, Mary F. Kearney, Eric O. Freed · 2021 · mBio
9. Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods
   Geetanjali Negi, Anurag Sharma, Manorama Dey, Garvita Dhanawat, Nagma Parveen · 2022 · Biophysical Reviews
10. HIV-1 tropism prediction by the XGboost and HMM methods
    Xiang Chen, Zhi‐Xin Wang, Xian‐Ming Pan · 2019 · Scientific Reports
11. Nano-based approaches in the development of antiviral agents and vaccines
    Yang Li, Yushuo Xiao, Yuchen Chen, Kun Huang · 2020 · Life Sciences
12. HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity
    Lisa K. Smith, Thomas B. Kuhn, Jack C. Chen, James R. Bamburg · 2018 · Current HIV Research
13. Novel Antiretroviral Therapeutic Strategies for HIV
    Rita F. Cunha, Sandra Simões, Manuela Carvalheiro, José Miguel Azevedo‐Pereira, Quirina Santos‐Costa, Andreia Ascenso · 2021 · Molecules
14. Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
    Amila Omeragic, Olanre Kayode, Md. Tozammel Hoque, Reina Bendayan · 2020 · Fluids and Barriers of the CNS
15. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
    Xinlei Li, Tao Peng · 2021 · Frontiers in Pharmacology
16. The Interplay of HIV and Autophagy in Early Infection
    Romina Cabrera-Rodríguez, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Daniel Márquez-Arce, Cecilia Cabrera, Lucile Espert, Julià Blanco, Agustı́n Valenzuela-Fernández · 2021 · Frontiers in Microbiology
17. Conformation-Dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors
    Axel M. Mann, Nikolas Friedrich, Anders Krarup, Jacqueline Weber, Emanuel Stiegeler, Birgit Dreier, Pavel Pugach, Melissa Robbiani, Tina Riedel, Kerstin Moehle et al. · 2013 · Journal of Virology
18. CCR6/CCL20 chemokine axis in human immunodeficiency virus immunity and pathogenesis
    Adrian Y. S. Lee, Heinrich Körner · 2016 · Journal of General Virology
19. Viral mechanisms for docking and delivering at nuclear pore complexes
    Justin W. Flatt, Urs F. Greber · 2017 · Seminars in Cell and Developmental Biology
20. In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells
    Masaru Yokoyama, Masako Nomaguchi, Naoya Doi, Tadahito Kanda, Akio Adachi, Hironori Sato · 2016 · Frontiers in Microbiology
21. Δ20 IFITM2 differentially restricts X4 and R5 HIV-1
    Wan‐Lin Wu, Christopher Robert Grotefend, Ming-Ting Tsai, Yiling Wang, Vladimir Radic, Hyungjin Eoh, I‐Chueh Huang · 2017 · Proceedings of the National Academy of Sciences
22. Rice stripe virus hitchhikes the vector insect vitellogenin ligand-receptor pathway for ovary entry
    Yan Huo, Yuanling Yu, Qing Liu, Da Liu, Mengting Zhang, Jingnan Liang, Xiaoying Chen, Lili Zhang, Rongxiang Fang · 2019 · Philosophical Transactions of the Royal Society B Biological Sciences
23. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation
    Shrinjana Dhar, Pritha Bhattacharjee · 2021 · Journal of Functional Foods
24. miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes
    Maria Teresa Quaranta, Eleonora Olivetta, Massimo Sanchez, Isabella Spinello, Rosa Paolillo, Claudia Arenaccio, Maurizio Federico, Catherine Labbaye · 2015 · Virology
25. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
    Lulia Koujah, Deepak Shukla, Afsar Raza Naqvi · 2019 · Seminars in Cell and Developmental Biology
26. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes
    Rajesh P. Ringe, Gabriel Ozorowski, Anila Yasmeen, Albert Cupo, Victor M. Cruz Portillo, Pavel Pugach, Michael Golabek, Kimmo I. Rantalainen, Lauren G. Holden, Christopher A. Cottrell et al. · 2017 · Journal of Virology
27. When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses
    Ehsan Ghasemian, Emma Michele Harding-Esch, David C. W. Mabey, Martin J. Holland · 2023 · Viruses
28. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response
    Madeline Rodríguez-Valentín, Sheila N. López Acevedo, Mariela Rivera, Eddy Ríos‐Olivares, Luis A. Cubano, Nawal M. Boukli · 2018 · Journal of Immunology Research
29. Proteo-Transcriptomic Dynamics of Cellular Response to HIV-1 Infection
    Monica Golumbeanu, Sébastien Desfarges, Céline Hernandez, Manfredo Quadroni, Sylvie Rato, Pejman Mohammadi, Amalio Telenti, Niko Beerenwinkel, Angela Ciuffi · 2019 · Scientific Reports
30. Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
    Sonu Kumar, Anita Sarkar, Pavel Pugach, Rogier W. Sanders, John P. Moore, Andrew B. Ward, Ian A. Wilson · 2019 · Nature Communications
31. CD4-Dependent Modulation of HIV-1 Entry by LY6E
    Jingyou Yu, Chen Liang, Shan‐Lu Liu · 2019 · Journal of Virology
32. Cholesterol Interaction with the Trimeric HIV Fusion Protein gp41 in Lipid Bilayers Investigated by Solid-State NMR Spectroscopy and Molecular Dynamics Simulations
    Byungsu Kwon, Taraknath Mandal, Matthew R. Elkins, Younghoon Oh, Qiang Cui, Mei Hong · 2020 · Journal of Molecular Biology
33. Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism
    Lisa K. Smith, Isaac William Babcock, Laurie S. Minamide, Alisa E. Shaw, James R. Bamburg, Thomas B. Kuhn · 2021 · PLoS ONE
34. Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy
    Rachel Wodarski, Deniz Bağdaş, Jason J. Paris, Tim Pheby, Wisam B. Toma, Ruqiang Xu, Mohamad Imad Damaj, Pamela E. Knapp, Andrew S.C. Rice, Kurt F. Hauser · 2018 · PAIN Reports
35. Gal power: the diverse roles of galectins in regulating viral infections
    Emily A. Machala, Brian Patrick McSharry, Barry T. Rouse, Allison Abendroth, Barry Slobedman · 2019 · Journal of General Virology
36. Antiviral adsorption activity of porous silicon nanoparticles against different pathogenic human viruses
    Liubov A. Osminkina, Svetlana N. Agafilushkina, Ekaterina A. Kropotkina, N. Yu. Saushkin, I. V. Bozhev, Sergei S. Abramchuk, Jeanne V. Samsonova, Alexandra S. Gambaryan · 2021 · Bioactive Materials
37. 30 years of HIV therapy: Current and future antiviral drug targets
    Julius Nuwagaba, Jessica A Li, Brandon Ngo, Richard E. Sutton · 2024 · Virology
38. Aptamer–siRNA Chimeras for HIV
    Mayumi M. Takahashi, John Burnett, John J. Rossi · 2015 · Advances in experimental medicine and biology
39. Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
    Soltani, Arash, Hashemy, Seyed Isaac, Zahedi Avval, Farnaz, Soleimani, Anvar, Rafatpanah, Houshang, Rezaee, Seyed Abdorahim, Griffith, Renate, Mashkani, Baratali · 2019 · Biomedicine & Pharmacotherapy
40. Receptor Conformation and Constitutive Activity in CCR5 Chemokine Receptor Function and HIV Infection
    Colleen A. Flanagan · 2014 · Advances in pharmacology
41. Development of peptide inhibitors of HIV transmission
    Siyu Shi, Peter K. Nguyen, Henry Cabral, Ramon Diez-Barroso, Paul J. Derry, Satoko M. Kanahara, Vivek Kumar · 2016 · Bioactive Materials
42. HIV-1 capsid and viral DNA integration
    Richa Dwivedi, Prem Prakash, Bajarang Vasant Kumbhar, Muthukumar Balasubramaniam, Chandravanu Dash · 2023 · mBio
43. Viral glycoproteomes: technologies for characterization and outlook for vaccine design
    I. Bagdonaite, S. Vakhrushev, H. Joshi, H. Wandall · 2018 · FEBS Letters
44. Antiviral Effects of Oleandrin
    Robert Alan Newman, K. Jagannadha Sastry, Ravit Arav‐Boger, Hongyi Cai, Jose R. Matos, Robert Harrod · 2020 · Journal of Experimental Pharmacology
45. NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics?
    Jacob C. Bjorgen, Jenna K. Dick, Ross T. Cromarty, Geoffrey T. Hart, Joshua Rhein · 2023 · Frontiers in Immunology
46. An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development
    Lotfi, Hajie, Sheervalilou, Roghayeh, Zarghami, Nosratollah · 2017 · BioImpacts
47. Evidence Showing that Tetraspanins Inhibit HIV-1-Induced Cell-Cell Fusion at a Post-Hemifusion Stage
    Menelaos Symeonides, Marie Lambelé, Nathan H. Roy, Markus Thali · 2014 · Viruses
48. HIV infection is influenced by dynamin at 3 independent points in the viral life cycle
    Anupriya Aggarwal, Tina L. Hitchen, Lars Ootes, Samantha McAllery, Andrew Kam Ho Wong, Khanh Nguyen, Adam McCluskey, Phillip James Robinson, Stuart Grant Turville · 2017 · Traffic
49. Affinofile profiling: How efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV
    Kelechi Chikere, Tom Chou, Paul R. Gorry, Benhur Lee · 2012 · Virology
50. eCD4-Ig Variants That More Potently Neutralize HIV-1
    Ina Fetzer, Matthew R. Gardner, Meredith E. Davis-Gardner, Neha R. Prasad, Barnett Alfant, Jesse A. Weber, Michael Farzan · 2018 · Journal of Virology
51. Lateral Membrane Heterogeneity Regulates Viral-Induced Membrane Fusion during HIV Entry
    Rodion J. Molotkovsky, Veronika V. Alexandrova, Timur R. Galimzyanov, Irene Jiménez-Munguía, Konstantin V. Pavlov, Oleg V. Batishchev, Sergey A. Akimov · 2018 · International Journal of Molecular Sciences
52. Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures
    Martina Donadoni, Senem Çakır, Anna Bellizzi, Michael Swingler, Ilker Kudret Sariyer · 2024 · Journal of NeuroVirology
53. The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications
    Leen Mathys, Jan M. Balzarini · 2015 · Expert Opinion on Therapeutic Targets
54. Chimeric Antigen Receptor Engineered Stem Cells: A Novel HIV Therapy
    Anjie Zhen, Mayra A. Carrillo, Scott G. Kitchen · 2017 · Immunotherapy
55. On the Whereabouts of HIV-1 Cellular Entry and Its Fusion Ports
    G. Maria Jakobsdottir, Maro Iliopoulou, Rory Nolan, Luis Álvarez, Alex A. Compton, Sergi Padilla‐Parra · 2017 · Trends in Molecular Medicine
56. HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
    Gabriel A. Valentin-Guillama, Sheila N. López Acevedo, Yuriy V. Kucheryavykh, Nataliya Chorna, Jose Pérez, Jescelica Ortiz-Rivera, Mikhail Y. Inyushin, Vladimir I. Makarov, Anibal Valentín-Acevedo, Alfredo Quiñones‐Hinojosa et al. · 2018 · Cancers
57. Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors
    Alexander M. Andrianov, Grigory I. Nikolaev, Nikita A. Shuldov, Ivan P. Bosko, Arseny I. Anischenko, Alexander V. Tuzikov · 2021 · Journal of Biomolecular Structure and Dynamics
58. Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review
    Holly Everest, Phoebe Stevenson-Leggett, Dalan Bailey, Erica Bickerton, Sarah Keep · 2022 · Viruses
59. Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV
    Chloe M. Orkin, Pedro Enrique Cahn, Antonella Castagna, Brinda Emu, P. Richard Harrigan, Daniel R. Kuritzkes, Mark Richard Nelson, Jonathan Schapiro · 2022 · HIV Medicine
60. Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase
    Rahul V. Patel, Se Won Park · 2015 · Bioorganic & Medicinal Chemistry
61. The chemokine receptor CCR5: multi-faceted hook for HIV-1
    Natacha Faivre, Christel Vérollet, Fabrice Dumas · 2024 · Retrovirology
62. Immunoinformatic Identification of Multiple Epitopes of gp120 Protein of HIV-1 to Enhance the Immune Response against HIV-1 Infection
    Arslan Habib, Yulai Liang, Xinyi Xu, Naishuo Zhu, Jun Xie · 2024 · International Journal of Molecular Sciences
63. Lipids in infectious diseases – The case of AIDS and tuberculosis
    Fabrice Dumas, Evert Haanappel · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
64. In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein
    Rolando Alberto Rodríguez-Fonseca, Martiniano Bello, María Ángeles de los Muñoz-Fernández, Javier López Jiménez, Saúl Rojas-Hernández, Manuel Jonathan Fragoso-Vázquez, Mara Gutiérrez‐Sánchez, João Rodrigues, Nicolas Cayetano-Castro, Raúl Borja‐Urby et al. · 2019 · Colloids and Surfaces B Biointerfaces
65. HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA
    Nicklas Sapp, Nathaniel L. Burge, Khan L. Cox, Santosh Thapa, Prem Prakash, Muthukumar Balasubramaniam, Devin E. Christensen, Min Li, Jared Linderberger, Mamuka Kvaratskhelia et al. · 2022 · Journal of Virology
66. Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review
    Ekaterine Mosidze, Gianluigi Franci, Federica Dell’Annunziata, Nicoletta Capuano, Marica Colella, Flora Salzano, Massimiliano Galdiero, Aliosha Bakuridze, Veronica Folliero · 2025 · Global Challenges
67. Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle
    Vanessa D’Urbano, Elisa De Crignis, Maria Carla Re · 2018 · Current HIV Research
68. Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors
    Chaozai Zhang, Ruohan Zhu, Qizhi Cao, Xiaohong Yang, Ziwei Huang, Jing An · 2020 · Experimental Biology and Medicine
69. Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders
    Divya T. Chemparthy, Muthukumar Kannan, Lila Gordon, Shilpa J. Buch, Susmita Sil · 2021 · Vaccines
70. Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro
    Kevin M. Tyo, Hung R. Vuong, Danial A. Malik, Lee B. Sims, Houda Alatassi, Jinghua Duan, Walter H. Watson, Jill M. Steinbach-Rankins · 2017 · International Journal of Pharmaceutics
71. Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
    Andrew F. Voter, James L. Keck · 2017 · Advances in protein chemistry and structural biology
72. Tetraspanins, Another Piece in the HIV-1 Replication Puzzle
    Henar Suárez, Vera Rocha‐Perugini, Susana Álvarez, María Yáñez‐Mó · 2018 · Frontiers in Immunology
73. Human Pannexin 1 channel: Insight in structure–function mechanism and its potential physiological roles
    Eijaz Ahmed Bhat, Nasreena Sajjad · 2021 · Molecular and Cellular Biochemistry
74. Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses
    Tania Mulherkar, Daniel Joseph Gómez, Grace Sandel, Pooja Jain · 2022 · Viruses
75. Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens
    Na Rong, Jiangning Liu · 2023 · Emerging Microbes & Infections
76. IP6‐stabilised HIV capsids evade cGAS/STING‐mediated host immune sensing
    Guido Papa, Anna Albecka, Donna L. Mallery, Marina Vaysburd, Nadine Renner, Leo C. James · 2023 · EMBO Reports
77. Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications
    Wenhao Li, Chenyu Yu, Xujian Zhang, Yunshen Gu, Xiaobo He, Rongrong Xu, Jia Feng Xu, Ganjun Yu, Yanfeng Wu · 2025 · Molecular Biomedicine
78. Concerted Interactions between Multiple gp41 Trimers and the Target Cell Lipidome May Be Required for HIV-1 Entry
    Biswajit Gorai, Anil Kumar Sahoo, Anand Kumar Srivastava, Narendra M. Dixit, Prabal Kumar Maiti · 2020 · Journal of Chemical Information and Modeling
79. New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection
    María de la Sierra Espinar-Buitrago, María Ángeles Muñoz‐Fernández · 2022 · Frontiers in Immunology
80. Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2
    Merve Ayşe Doğancı, Fulya Ay Sal, Halil İbrahim Güler, Hatice Katı, Esma Ceylan, Ali Osman Beldüz, Gözde Bozdal, Nurettin Yaylı, Sabriye Çanakçı · 2022 · World Journal of Microbiology and Biotechnology
81. The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles
    Madison M. Johnson, Carson Everest Jones, Daniel N. Clark · 2022 · Viruses
82. Chimeric Cyanovirin-MPER Recombinantly Engineered Proteins Cause Cell-Free Virolysis of HIV-1
    Mark Contarino, Arangassery Rosemary Bastian, Ramalingam Venkat Kalyana Sundaram, Karyn McFadden, Caitlin Duffy, Vamshi K. Gangupomu, Michelle K. Baker, Cameron F. Abrams, IRWIN M. CHAIKEN · 2013 · Antimicrobial Agents and Chemotherapy
83. HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
    Philip R. Tedbury, Eric O. Freed · 2015 · Current topics in microbiology and immunology
84. Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
    Quentin James Sattentau · 2013 · Vaccines
85. A biophysical perspective on receptor-mediated virus entry with a focus on HIV
    Isabel Llorente‐Garcia, Mark Marsh · 2019 · Biochimica et Biophysica Acta (BBA) - Biomembranes
86. Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections
    Kamyar Khoshnevisan, Hassan Maleki, Hadi Baharifar · 2021 · Nanoscale Research Letters
87. A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
    Emma Parker Miller, Maxwell T. Finkelstein, Molly C. Erdman, Paul C. Seth, Daniela Fera · 2021 · Viruses
88. Mechanisms of HIV-1 cell-to-cell transfer to myeloid cells
    Mingyu Han, Marie Woottum, Rémi Mascarau, Zoï Vahlas, Christel Vérollet, Serge Bénichou · 2022 · Journal of Leukocyte Biology
89. Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane
    Toshana L. Foster, Suzanne Pickering, Stuart J. D. Neil · 2018 · Frontiers in Immunology
90. Adenovirus-Mimetic Nanoparticles: Sequential Ligand–Receptor Interplay as a Universal Tool for Enhanced In Vitro/In Vivo Cell Identification
    Daniel Fleischmann, Sara Maslanka Figueroa, Sebastian Beck, Kathrin Abstiens, Ralph Witzgall, Frank Schweda, Philipp Tauber, Achim M. Göpferich · 2020 · ACS Applied Materials & Interfaces
91. Strategies and Progress in CXCR4-Targeted Anti-Human Immunodeficiency Virus (HIV) Therapeutic Development
    Lina Huang, Evan Y. Snyder, Robert Turner Schooley · 2021 · Clinical Infectious Diseases
92. Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry
    Belinda L. Spillings, Christopher J. Day, Albert Garcia Minambres, Anupriya Aggarwal, Nicholas D. Condon, Thomas Haselhorst, Damian F. J. Purcell, Stuart Grant Turville, Jennifer Lea Stow, Michael P. Jennings et al. · 2022 · Cell Reports
93. Pathogenesis and Treatment of HIV Infection: The Cellular, the Immune System and the Neuroendocrine Systems Perspective
    В. А. Черешнев, Gennady Alekseevich Bocharov, Sergei I. Bazhan, B.A. Bachmetyev, I. Gainova, Vitaly A. Likhoshvai, Jordi M. Argilaguet, Javier P. Martínez, J. A. Rump, Beatriz Mothe et al. · 2013 · International Reviews of Immunology
94. Basic Concepts
    Robert W. Doms · 2016 · Elsevier eBooks
95. Friends and Foes: The Ambivalent Role of Autophagy in HIV-1 Infection
    Susanne Klute, Konstantin M. J. Sparrer · 2024 · Viruses
96. HIV-1 Nef Signaling in Intestinal Mucosa Epithelium Suggests the Existence of an Active Inter-kingdom Crosstalk Mediated by Exosomes
    Cristina Felli, Olimpia Vincentini, Marco Silano, Andrea Masotti · 2017 · Frontiers in Microbiology
97. The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays
    Bhaven A. Mistry, Maria Rita D'Orsogna, Tom Chou · 2018 · Biophysical Journal
98. Phage display: an important tool in the discovery of peptides with anti-HIV activity
    Ronaldo Lopes de Sousa, Maria Alice Freitas Queiroz, Samara Tatielle Monteiro Gomes, Antônio Carlos Rosário Vallinoto, Luíz Ricardo Goulart, Ricardo Ishak · 2018 · Biotechnology Advances
99. The extracellular vesicles in HIV infection and progression: mechanisms, and theranostic implications
    Zhen Tang, Yao Lu, Jiu-Long Dong, Wen Wu, Jian Li · 2024 · Frontiers in Bioengineering and Biotechnology
100. Do Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection?
     Glenda M. Davison, Heather L. Hendrickse, Tandi Edith Matsha · 2020 · Cells